{"id":29088,"date":"2025-12-09T16:19:37","date_gmt":"2025-12-09T16:19:37","guid":{"rendered":"https:\/\/alivira.es\/?p=29088"},"modified":"2025-12-10T16:55:31","modified_gmt":"2025-12-10T16:55:31","slug":"alivira-launches-diclacare-in-several-european-markets","status":"publish","type":"post","link":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/","title":{"rendered":"Alivira Launches Diclacare\u00ae in Several European Markets"},"content":{"rendered":"<p>Diclacare\u00ae 2.5 mg\/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group.<\/p>\n<p>Diclacare\u00ae 2.5 mg\/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves.<br \/>\nWhen administered before the onset of symptoms, preventive treatment aimed at animals in the early stages of the infectious cycle significantly reduces the severity of the disease and oocyst production, as well as improving weight gain. It is given orally in a single dose of 1 ml per 2.5 kg of body weight.<\/p>\n<p>Available in 1- and 2.5-liter containers, Diclacare\u00ae 2.5 mg\/ml is being launched in several European Union countries, including Spain, Portugal, Italy, Ireland, and Greece.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diclacare\u00ae 2.5 mg\/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare\u00ae 2.5 mg\/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves. When administered before the onset of [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":29089,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[],"class_list":["post-29088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Alivira Launches Diclacare\u00ae in Several European Markets - Alivira Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alivira Launches Diclacare\u00ae in Several European Markets\" \/>\n<meta property=\"og:description\" content=\"Diclacare\u00ae 2.5 mg\/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare\u00ae 2.5 mg\/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves. When administered before the onset of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/\" \/>\n<meta property=\"og:site_name\" content=\"Alivira Espa\u00f1a\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-09T16:19:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-10T16:55:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN-1030x549.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1030\" \/>\n\t<meta property=\"og:image:height\" content=\"549\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"tempadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"tempadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/\"},\"author\":{\"name\":\"tempadmin\",\"@id\":\"https:\\\/\\\/alivira.es\\\/#\\\/schema\\\/person\\\/dd6251223a0e7890e6c64fc46fd1588a\"},\"headline\":\"Alivira Launches Diclacare\u00ae in Several European Markets\",\"datePublished\":\"2025-12-09T16:19:37+00:00\",\"dateModified\":\"2025-12-10T16:55:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/\"},\"wordCount\":131,\"image\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/alivira.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Diclacare-EN.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/\",\"url\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/\",\"name\":\"Alivira Launches Diclacare\u00ae in Several European Markets - Alivira Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/alivira.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Diclacare-EN.jpg\",\"datePublished\":\"2025-12-09T16:19:37+00:00\",\"dateModified\":\"2025-12-10T16:55:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/#\\\/schema\\\/person\\\/dd6251223a0e7890e6c64fc46fd1588a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/alivira.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Diclacare-EN.jpg\",\"contentUrl\":\"https:\\\/\\\/alivira.es\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Diclacare-EN.jpg\",\"width\":11108,\"height\":5918},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/alivira.es\\\/en\\\/alivira-launches-diclacare-in-several-european-markets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\\\/\\\/alivira.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alivira Launches Diclacare\u00ae in Several European Markets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/alivira.es\\\/#website\",\"url\":\"https:\\\/\\\/alivira.es\\\/\",\"name\":\"Alivira Spain\",\"description\":\"Salud Animal\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/alivira.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/alivira.es\\\/#\\\/schema\\\/person\\\/dd6251223a0e7890e6c64fc46fd1588a\",\"name\":\"tempadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g\",\"caption\":\"tempadmin\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alivira Launches Diclacare\u00ae in Several European Markets - Alivira Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/","og_locale":"en_US","og_type":"article","og_title":"Alivira Launches Diclacare\u00ae in Several European Markets","og_description":"Diclacare\u00ae 2.5 mg\/ml is the new oral suspension for lambs and calves based on diclazuril from the Alivira group. Diclacare\u00ae 2.5 mg\/ml is authorized for the prevention of clinical signs of coccidiosis caused by Eimeria crandallis and Eimeria ovinoidalis in lambs, and Eimeria bovis and Eimeria zuernii in calves. When administered before the onset of [&hellip;]","og_url":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/","og_site_name":"Alivira Espa\u00f1a","article_published_time":"2025-12-09T16:19:37+00:00","article_modified_time":"2025-12-10T16:55:31+00:00","og_image":[{"width":1030,"height":549,"url":"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN-1030x549.jpg","type":"image\/jpeg"}],"author":"tempadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"tempadmin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#article","isPartOf":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/"},"author":{"name":"tempadmin","@id":"https:\/\/alivira.es\/#\/schema\/person\/dd6251223a0e7890e6c64fc46fd1588a"},"headline":"Alivira Launches Diclacare\u00ae in Several European Markets","datePublished":"2025-12-09T16:19:37+00:00","dateModified":"2025-12-10T16:55:31+00:00","mainEntityOfPage":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/"},"wordCount":131,"image":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/","url":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/","name":"Alivira Launches Diclacare\u00ae in Several European Markets - Alivira Espa\u00f1a","isPartOf":{"@id":"https:\/\/alivira.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#primaryimage"},"image":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN.jpg","datePublished":"2025-12-09T16:19:37+00:00","dateModified":"2025-12-10T16:55:31+00:00","author":{"@id":"https:\/\/alivira.es\/#\/schema\/person\/dd6251223a0e7890e6c64fc46fd1588a"},"breadcrumb":{"@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#primaryimage","url":"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN.jpg","contentUrl":"https:\/\/alivira.es\/wp-content\/uploads\/2025\/12\/Diclacare-EN.jpg","width":11108,"height":5918},{"@type":"BreadcrumbList","@id":"https:\/\/alivira.es\/en\/alivira-launches-diclacare-in-several-european-markets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/alivira.es\/en\/"},{"@type":"ListItem","position":2,"name":"Alivira Launches Diclacare\u00ae in Several European Markets"}]},{"@type":"WebSite","@id":"https:\/\/alivira.es\/#website","url":"https:\/\/alivira.es\/","name":"Alivira Spain","description":"Salud Animal","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alivira.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/alivira.es\/#\/schema\/person\/dd6251223a0e7890e6c64fc46fd1588a","name":"tempadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40315b0a88ac92039ac0887482d6f2b51f9cee1086097c3d953023a74dd414b1?s=96&d=mm&r=g","caption":"tempadmin"}}]}},"_links":{"self":[{"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/posts\/29088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/comments?post=29088"}],"version-history":[{"count":1,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/posts\/29088\/revisions"}],"predecessor-version":[{"id":29091,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/posts\/29088\/revisions\/29091"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/media\/29089"}],"wp:attachment":[{"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/media?parent=29088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/categories?post=29088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alivira.es\/en\/wp-json\/wp\/v2\/tags?post=29088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}